REQUEST A DEMO
Total
USD $0.00
Search more companies

Imporclinicas Jg S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Imporclinicas Jg S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Imporclinicas Jg S.A.S. is an enterprise based in Colombia. Its main office is in Barranquilla. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on May 12, 2011. It currently has a total number of 12 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 12.73% in 2023. Its total assets decreased by 0.6% over the same period. The net profit margin of Imporclinicas Jg S.A.S. increased by 1.63% in 2023.

Headquarters
Cr 50 Cl 80 18 Lc 4
Barranquilla; Atlantico;

Contact Details: Purchase the Imporclinicas Jg S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Imporclinicas Jg S.A.S. report to view the information.
Outstanding Shares:
Purchase the Imporclinicas Jg S.A.S. report to view the information.
Incorporation Date:
May 12, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Imporclinicas Jg S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
12.73%
Total operating revenue
12.73%
Operating profit (EBIT)
50.03%
Net Profit (Loss) for the Period
47.75%
Total assets
-0.6%
Total equity
25.42%
Operating Profit Margin (ROS)
2.98%
Net Profit Margin
1.63%
Return on Equity (ROE)
3.07%
Quick Ratio
0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?